Sign in
Taking peopleNo phase

NEUROprotection Via optimizINg Cerebral Blood Flow afTer cArdiaC arresT (NEURO-INTACT) Study

Key facts

Who runs it
National University Hospital, Singapore
Where
Singapore1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
49 people, planned
Started
29 Aug 2023
Planned end
Aug 2026
Type of study
Interventional
Treatments tested
  • Individualized blood pressure strategy
Record updated
16 May 2025

Who can take part

Age
21 years to 79 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • At least 21 years of age
  • Comatose defined as not being able to obey verbal commands and no verbal response to pain after sustained ROSC

Who cannot take part

  • Limitations of care or life support therapy withdrawn within 24 hours of admission
  • ≥ 80 years old at time of enrolment
  • Pregnant patients

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 21 and 79 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This single-center proof of concept study aims to assess the efficacy of a blood pressure strategy targeting person- and time-specific cerebral blood flow compared with standard-of-care using neuron-specific enolase as a quantitative biomarker of brain injury. Our central hypothesis is that an individualized blood pressure strategy targeting cerebral perfusion will reduce the extent of brain injury as indicated by changes in levels of neuron-specific enolase from baseline at 72 hours. To test this hypothesis, we will recruit 49 patients to an individualized blood pressure management strategy targeting cerebral blood flow, where optimal blood pressure will be serially calculated by the ICM+ brain monitoring software (Cambridge, UK) using inputs from transcranial Doppler ultrasound and near-infrared spectroscopy.

The group in the trial

  • Individualized blood pressure strategyTreatment being tested

    Hemodynamic optimization performed to an individualized target mean arterial pressure in the first 72 hours post ROSC based on cerebral perfusion assessed serially.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT05679739, who can take part
Publications
Record updated
16 May 2025